Skip to main content

Henry Schein guidance

  • HSIC · Nasdaq
  • Distribution
  • Health Care Distributors
  • S&P 500
$84.61−0.42%Close 17 Nov 2026 · Market value $9.31B

In its results release of 3 Nov 2026 (Q3 FY2026), Henry Schein gave 1 forecast in figures, among them EPS (adjusted) of $5.42 to $5.48 for FY2026.

Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.

Latest guidance given with Q3 FY2026 results, 3 Nov 2026

MeasurePeriodGuidanceAs stated
EPS · AdjustedFY2026$5.42 to $5.48FY2026 non-GAAP diluted EPS guidance updated to $5.42 to $5.48 solely to reflect the change

Source: the company's earnings release.

Guidance against results last two years

The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.

MeasurePeriodLast guidanceRevisionsDeliveredResult
Revenue growthFY2026About +3% to +5%Given once—To come
EPS · AdjustedFY2026$5.42 to $5.48Raised once—To come
Revenue growthFY2025About +3% to +4%Raised once+4.03%Within the range
Revenue growthFY2024+4% to +5%Given once+2.71%Below the range

HSIC in the terminal

Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.